 high surviv rate advanced-stag b-cell lymphoma leukemia cn involv short intens polychemotherapi result french pediatr oncolog societi random trial children april decemb french pediatr oncolog societi sfop random trial advanced-stag b-cell lymphoma cn involv possibl length treatment month intens six-drug induct cours high-dos fraction cyclophosphamid high-dos methotrex HD mtx cytarabin continu infus patient remiss complet remiss CR long arm addit cours addit drug week treatment short arm addit cours week patient partial remiss PR intensif treatment sixteen patient stage II nasopharyng extens facial tumor stage iii stage IV latter blast cell bone marrow primari site involv abdomen head neck thorax site sixty-seven patient aliv first CR minimum follow-up month follow-up patient initi treatment failur toxic death unrel treatment event-fre surviv ef median follow-up month SE patient SE stage II patient SE stage iii patient SE stage IV acut lymphoblast leukemia all patient sixty-six patient short arm long arm ef statist analysi equival treatment arm regard ef morbid short arm studi high surviv rate previou lmb studi radiotherapi debulk surgeri effect short treatment